- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Essilor acquires interest in Puerto Rico lab
Dallas—Essilor of America has acquired majority interest in MGM Optical Laboratory Inc., a lab serving the Puerto Rico market that handles $2 million in annual revenue.
Dallas-Essilor of America has acquired majority interest in MGM Optical Laboratory Inc., a lab serving the Puerto Rico market that handles $2 million in annual revenue.
"MGM is the most up-to-date lab on the island of Puerto Rico and is one of the major players in the optical market," said John Carrier, president of Essilor Laboratories of America.
The deal allows Essilor to offer its products through MGM's ordering locations and customers, boosting a market that has posed a problem because of its distance to the mainland United States, Carrier said. Current leadership will remain in place.
